Tribehenin

Tribehenin is a lipid of Glycerolipids (GL) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 850 references associated with Tribehenin in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

Here are additional resources we collected from PubChem and MeSH for Tribehenin

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Tribehenin

MeSH term MeSH ID Detail
Candidiasis, Vulvovaginal D002181 8 associated lipids
Angina Pectoris D000787 27 associated lipids
Edema D004487 152 associated lipids
Total 3

NCBI Entrez Crosslinks

All references with Tribehenin

Download all related citations
Per page 10 20 50 100 | Total 169
Authors Title Published Journal PubMed Link
Rahman Z et al. Non-destructive methods of characterization of risperidone solid lipid nanoparticles. 2010 Eur J Pharm Biopharm pmid:20470882
Rajkumar M and Bhise S Carbamazepine-loaded porous microspheres for short-term sustained drug delivery. 2010 J Young Pharm pmid:21331184
Jeong SH and Park K Simple preparation of coated resin complexes and their incorporation into fast-disintegrating tablets. 2010 Arch. Pharm. Res. pmid:20191352
Durand L et al. Encapsulation of ethylhexyl methoxycinnamate, a light-sensitive UV filter, in lipid nanoparticles. 2010 J Microencapsul pmid:21034364
Urbán-Morlán Z et al. Preparation and characterization of solid lipid nanoparticles containing cyclosporine by the emulsification-diffusion method. 2010 Int J Nanomedicine pmid:20856836
Patel JK et al. In vitro controlled release of colon targeted mesalamine from compritol ATO 888 based matrix tablets using factorial design. 2009 Res Pharm Sci pmid:21589801
Lin YC et al. Glycerol monolaurate and dodecylglycerol effects on Staphylococcus aureus and toxic shock syndrome toxin-1 in vitro and in vivo. 2009 PLoS ONE pmid:19838303
Scalia S and Mezzena M Incorporation in lipid microparticles of the UVA filter, butyl methoxydibenzoylmethane combined with the UVB filter, octocrylene: effect on photostability. 2009 AAPS PharmSciTech pmid:19381836
Scalia S and Mezzena M Co-loading of a photostabilizer with the sunscreen agent, butyl methoxydibenzoylmethane in solid lipid microparticles. 2009 Drug Dev Ind Pharm pmid:18785040
Mukherjee S et al. Solid lipid nanoparticles: a modern formulation approach in drug delivery system. 2009 Indian J Pharm Sci pmid:20502539
Bhalekar MR et al. Preparation and evaluation of miconazole nitrate-loaded solid lipid nanoparticles for topical delivery. 2009 AAPS PharmSciTech pmid:19294517
Kuo YC and Chen HH Entrapment and release of saquinavir using novel cationic solid lipid nanoparticles. 2009 Int J Pharm pmid:18848610
Rao M et al. Mechanistic evaluation of the effect of sintering on Compritol 888 ATO matrices. 2009 AAPS PharmSciTech pmid:19333763
Gökçe EH et al. The effect of geometric shape on the release properties of metronidazole from lipid matrix tablets. 2009 J Biomed Nanotechnol pmid:20055089
Barakat NS et al. Controlled-release carbamazepine matrix granules and tablets comprising lipophilic and hydrophilic components. 2009 Drug Deliv pmid:19555310
Abdelbary G and Fahmy RH Diazepam-loaded solid lipid nanoparticles: design and characterization. 2009 AAPS PharmSciTech pmid:19277870
Gohel M and Nagori SA Fabrication and evaluation of captopril modified-release oral formulation. 2009 Pharm Dev Technol pmid:19883258
UÄŸurlu T and TurkoÄŸlu M Hexagonal boron nitride as a tablet lubricant and a comparison with conventional lubricants. 2008 Int J Pharm pmid:18160235
Sengel-Türk CT et al. Microsphere-based once-daily modified release matrix tablets for oral administration in angina pectoris. 2008 J Microencapsul pmid:18465309
Yuan H et al. Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells. 2008 Int J Pharm pmid:17714896
Dalpiaz A et al. Solid lipid microparticles for the stability enhancement of the polar drug N6-cyclopentyladenosine. 2008 Int J Pharm pmid:18178347
Montana G et al. Employment of cationic solid-lipid nanoparticles as RNA carriers. 2007 Mar-Apr Bioconjug. Chem. pmid:17253655
Castro GA et al. Development of a new solid lipid nanoparticle formulation containing retinoic acid for topical treatment of acne. 2007 J Microencapsul pmid:17578730
Tursilli R et al. Solid lipid microparticles containing the sunscreen agent, octyl-dimethylaminobenzoate: effect of the vehicle. 2007 Eur J Pharm Biopharm pmid:17407809
Hou DZ et al. [Microstructure of novel solid lipid nanoparticle loaded triptolide]. 2007 Yao Xue Xue Bao pmid:17633214
Chen G et al. [Preliminary study on brain-targeted drug delivery via inner ear]. 2007 Yao Xue Xue Bao pmid:18229622
Ozyazici M et al. In vitro release--in vivo microbiological and toxicological studies on ketoconazole lipid granules. 2007 Pharm Dev Technol pmid:18161631
Thakkar H et al. Enhanced retention of celecoxib-loaded solid lipid nanoparticles after intra-articular administration. 2007 Drugs R D pmid:17767393
Lai F et al. SLN as a topical delivery system for Artemisia arborescens essential oil: in vitro antiviral activity and skin permeation study. 2007 Int J Nanomedicine pmid:18019840
Brubach JB et al. Structural and thermal characterization of glyceryl behenate by X-ray diffraction coupled to differential calorimetry and infrared spectroscopy. 2007 Int J Pharm pmid:17207945
Ghimire M et al. In-vitro/in-vivo correlation of pulsatile drug release from press-coated tablet formulations: a pharmacoscintigraphic study in the beagle dog. 2007 Eur J Pharm Biopharm pmid:17498934
Videira MA et al. Lymphatic uptake of lipid nanoparticles following endotracheal administration. 2006 J Microencapsul pmid:17390627
Pedersen N et al. Solid lipid nanoparticles can effectively bind DNA, streptavidin and biotinylated ligands. 2006 Eur J Pharm Biopharm pmid:16290122
Souto EB et al. Polymorphic behaviour of Compritol888 ATO as bulk lipid and as SLN and NLC. 2006 J Microencapsul pmid:16854817
Hamdani J et al. Development and in vitro evaluation of a novel floating multiple unit dosage form obtained by melt pelletization. 2006 Int J Pharm pmid:16824707
Li FQ et al. In vitro controlled release of sodium ferulate from Compritol 888 ATO-based matrix tablets. 2006 Int J Pharm pmid:16837152
Hamdani J et al. In vitro and in vivo evaluation of floating riboflavin pellets developed using the melt pelletization process. 2006 Int J Pharm pmid:16815656
Furlanetto S et al. Study of formulation variables influencing the drug release rate from matrix tablets by experimental design. 2006 Eur J Pharm Biopharm pmid:16154333
Gavini E et al. Solid lipid microparticles (SLM) containing juniper oil as anti-acne topical carriers: preliminary studies. 2005 Pharm Dev Technol pmid:16370177
He J et al. [Effect of particle size on oral absorption of silymarin-loaded solid lipid nanoparticles]. 2005 Zhongguo Zhong Yao Za Zhi pmid:16400939
Souto EB and Müller RH SLN and NLC for topical delivery of ketoconazole. 2005 J Microencapsul pmid:16361193
Lombardi Borgia S et al. Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy. 2005 J Control Release pmid:16297487
Quintanar-Guerrero D et al. Adaptation and optimization of the emulsification-diffusion technique to prepare lipidic nanospheres. 2005 Eur J Pharm Sci pmid:16046105
Hu LD et al. [Preparation of solid lipid nanoparticles loaded with all-trans retinoic acid and their evaluation in vitro and in vivo]. 2005 Yao Xue Xue Bao pmid:15881775
Turkoglu M et al. Evaluation of hexagonal boron nitride as a new tablet lubricant. 2005 Pharm Dev Technol pmid:16176018
Jores K et al. Solid lipid nanoparticles (SLN) and oil-loaded SLN studied by spectrofluorometry and Raman spectroscopy. 2005 Pharm. Res. pmid:16132349
Gu X et al. Evaluation and comparison of five matrix excipients for the controlled release of acrivastine and pseudoephedrine. 2004 Drug Dev Ind Pharm pmid:15595567
Final report of the amended safety assessment of Glyceryl Laurate, Glyceryl Laurate SE, Glyceryl Laurate/Oleate, Glyceryl Adipate, Glyceryl Alginate, Glyceryl Arachidate, Glyceryl Arachidonate, Glyceryl Behenate, Glyceryl Caprate, Glyceryl Caprylate, Glyceryl Caprylate/Caprate, Glyceryl Citrate/Lactate/Linoleate/Oleate, Glyceryl Cocoate, Glyceryl Collagenate, Glyceryl Erucate, Glyceryl Hydrogenated Rosinate, Glyceryl Hydrogenated Soyate, Glyceryl Hydroxystearate, Glyceryl Isopalmitate, Glyceryl Isostearate, Glyceryl Isostearate/Myristate, Glyceryl Isostearates, Glyceryl Lanolate, Glyceryl Linoleate, Glyceryl Linolenate, Glyceryl Montanate, Glyceryl Myristate, Glyceryl Isotridecanoate/Stearate/Adipate, Glyceryl Oleate SE, Glyceryl Oleate/Elaidate, Glyceryl Palmitate, Glyceryl Palmitate/Stearate, Glyceryl Palmitoleate, Glyceryl Pentadecanoate, Glyceryl Polyacrylate, Glyceryl Rosinate, Glyceryl Sesquioleate, Glyceryl/Sorbitol Oleate/Hydroxystearate, Glyceryl Stearate/Acetate, Glyceryl Stearate/Maleate, Glyceryl Tallowate, Glyceryl Thiopropionate, and Glyceryl Undecylenate. 2004 Int. J. Toxicol. pmid:15513825
Hariharan M et al. Effect of formulation composition on the properties of controlled release tablets prepared by roller compaction. 2004 Drug Dev Ind Pharm pmid:15285329
Jores K et al. Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy. 2004 J Control Release pmid:14980770